Featured News

  • A Statement from the American Clinical Laboratory Association (ACLA) on the Clinical Laboratory Fee Schedule (CLFS) provisions in the SGR Extension Legislation

    March 26, 2014
    WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) — a not-for-profit association representing the nation’s leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies –issued the following statement regarding the Clinical Laboratory Fee Schedule (CLFS) provisions in the SGR extension legislation that was posted in the US House of Representatives earlierContinue Reading »...
  • American Clinical Laboratory Association Names Steve Rusckowski, CEO of Quest Diagnostics, as New Chairman of the Board

    March 24, 2014
    WASHINGTON, D.C. –   The American Clinical Laboratory Association (ACLA) announced it has approved the nomination of Quest Diagnostics CEO Stephen H. Rusckowski, as Chairman of the Board for the national association representing clinical laboratories. Mr. Rusckowski was nominated by the ACLA Board of Directors and approved by the membership during ACLA’s annual conference. “Clinical laboratory testing provides insights that help improve healthcare decision making,Continue Reading »...
  • Importance of Clinical Lab Testing for Patients At Risk of Chronic Kidney Disease Heralded During National Kidney Month

    March 21, 2014
      WASHINGTON, D.C. – Noting the critical role routine clinical lab tests play in the diagnosis of Chronic Kidney Disease (CKD) and many other diseases – such as diabetes and high blood pressure – that may lead to or develop following a CKD diagnosis, the American Clinical Laboratory Association (ACLA) today recognized National Kidney Month this March as a time to increase education andContinue Reading »...
  • ACLA and G2 Intelligence Hold Webinar On CMS Rule Allowing Patients’ Direct Access to Lab Results

    March 20, 2014
    WASHINGTON, D.C. –  In order to provide perspective and impact analysis for clinical laboratory professionals regarding a recently announced rule by the Centers for Medicare and Medicaid Services (CMS) that would allow consumers direct access to their lab results, the American Clinical Laboratory Association (ACLA) and G2 Intelligence, an organization reporting on the diagnostic industry for more than 30 years, will sponsor a webinarContinue Reading »...
  • American Clinical Laboratory Association Addresses Medicare Reimbursement Challenges at 2014 Annual Meeting

    March 18, 2014
    Washington, D.C. –  The American Clinical Laboratory Association (ACLA) today opened its 19th Annual Meeting entitled “Navigating the Reimbursement Maze: Challenges and Opportunities Facing Laboratories in the 21st Century,” drawing over 100 clinical laboratory professionals from across the country and featuring health policy experts that will address regulatory policy and funding challenges impacting clinical laboratories.   “As an industry, clinical labs provide the mostContinue Reading »...
  • ‘No rationale’ for Tricare’s refusal to cover genetic tests

    March 11, 2014
    A change in medical classifications last year has left clinical laboratories across the U.S. carrying a $10 million tab for Tricare. Tricare beneficiaries have not been billed for certain physician-ordered tests they have received at clinical laboratories since Jan. 1, 2013 — but Tricare also has not paid for them. At the heart of the standoff are genetic tests developed by laboratories that areContinue Reading »...
  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
  • ACLA on President’s FY 2015 Budget

    March 04, 2014
    (Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today pointed to both beneficial and harmful provisions in the President’s FY 2015 budget: drastic funding cuts that would compromise the continued delivery of high quality clinical lab services to Medicare beneficiaries and a proposal that would preserve integrity in the lab services industry. ACLA urged congressional budget leaders to oppose provisions that would reduceContinue Reading »...
  • ACLA: TRICARE Decision to Deny Coverage of Molecular Diagnostic Tests Compromises Standard of Care for Military Families

    February 26, 2014
    (Washington, D.C.) – In a statement to the House Armed Services Subcommittee on Military Personnel addressing a hearing on the Defense Health Agency (DHA), the American Clinical Laboratory Association (ACLA) today expressed strong opposition to TRICARE’s current policy of non-coverage for molecular diagnostic tests provided to TRICARE beneficiaries seeking care through the community provider network. “There is no sound clinical or regulatory rationale forContinue Reading »...
  • Lab testing a Medicare cost saver

    February 18, 2014
    Sen. Ron Wyden (D-Ore.), the new chairman of the Senate Finance Committee and a longtime champion of improving chronic disease care, is in a position to play an important role in reforming Medicare. Wyden has long advocated a Medicare program that would feature improved care coordination for chronic disease, which would save lives and improve the quality of life for beneficiaries, while saving MedicareContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14